Oral Oncology Reports

Elsevier

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Oral Oncology Reports is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,270 USD. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2772-9060
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,270 USD
Articles in DOAJ
745
Declared review time
8 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2024-08-22
Indexing
DOAJ
APC
2,270 USD
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

745

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

781

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

16

i10-index

47

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2024-08-22
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
98%
ORCID iDs in current deposits
83%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918681183706676
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Head and Neck Cancer Studies
  • Head and Neck Cancer Studies
  • Head and Neck Cancer Studies
  • Oral Health Pathology and Treatment
  • Oral Health Pathology and Treatment
  • Oral Health Pathology and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Head and Neck Surgical Oncology
Show all subjects (75)
  • Oral and Maxillofacial Pathology
  • Oral and Maxillofacial Pathology
  • Salivary Gland Tumors Diagnosis and Treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Oral health in cancer treatment
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Oral health in cancer treatment
  • Oral health in cancer treatment
  • AI in cancer detection
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Oral and Maxillofacial Pathology
  • Artificial Intelligence in Healthcare and Education
  • Salivary Gland Tumors Diagnosis and Treatment
  • Artificial Intelligence in Healthcare and Education
  • Artificial Intelligence in Healthcare and Education
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Head and Neck Surgical Oncology
  • Head and Neck Surgical Oncology
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Ear and Head Tumors
  • Ear and Head Tumors
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • HIV/AIDS oral health manifestations
  • Reconstructive Surgery and Microvascular Techniques
  • Salivary Gland Disorders and Functions
  • Nanoplatforms for cancer theranostics
  • Reconstructive Facial Surgery Techniques
  • Cancer survivorship and care
  • Advanced Radiotherapy Techniques
  • Nanoparticle-Based Drug Delivery
  • Reconstructive Surgery and Microvascular Techniques
  • Reconstructive Surgery and Microvascular Techniques
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Nonmelanoma Skin Cancer Studies
  • Immunotherapy and Immune Responses
  • AI in cancer detection
  • Cancer Cells and Metastasis
  • Immunotherapy and Immune Responses
  • AI in cancer detection
  • MicroRNA in disease regulation
  • Cancer-related molecular mechanisms research
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Oral microbiology and periodontitis research
  • MicroRNA in disease regulation
  • CAR-T cell therapy research
  • Cancer Cells and Metastasis
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Cancer Cells and Metastasis
  • Cervical Cancer and HPV Research
  • Tumors and Oncological Cases
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • Tumors and Oncological Cases
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Esophageal Cancer Research and Treatment

Keywords (DOAJ)

  • head and neck
  • cancer
  • oral cancer
  • neoplasm
  • carcinoma
  • tumor

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: